Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies
Webinar/Online
Thursday, January 22, 2026 at 3:30pm ET - 4:30pm ET
Add this event to your calendar
Info
Topic
Join us for this live, interactive webinar designed to advance evidence-based, personalized care for veterans with metastatic hormone-sensitive prostate cancer (mHSPC). Co-presented by two leading prostate cancer experts, this webinar will cover expert guidelines and VA Oncology Clinical Pathways and the latest clinical data for current and emerging therapies in mHSPC. Through case discussion, live polling, and Q&A, you'll gain practical strategies for integrating novel agents, managing adverse events, and enhancing multidisciplinary collaboration. You'll also gain access to a downloadable tool to support clinical trial identification and referrals. Strengthen your team's ability to deliver veteran-centered, evidence-based care across VA settings.
Credits Offered
This event offers
1.0 contact hour
to attendees.
Accreditation Info:
AANP.
Additional Information
Join us for this live, interactive webinar designed to advance evidence-based, personalized care for veterans with metastatic hormone-sensitive prostate cancer (mHSPC).
Speakers
Assistant Professor of Medicine
Harvard Medical School
Director of Clinical Research
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, MA
Professor of Medicine, Medical Oncology Division
University of Washington School of Medicine
Fred Hutchinson Cancer Center
Seattle, WA
Bruce Montgomery, MD, is a board certified oncologist, Professor of Medicine, Oncology and Urology, University of Washington, Fred Hutch Cancer Center, and VA Puget Sound HCS. He is clinical Director of the VA/PCF POPCAP network. Dr. Montgomery sees patients and conducts clinical trials across all institutions. Dr. Montgomery earned his M.D. at Duke, did residency training at Brigham and Women's hospital and fellowship at Fred Huchinson Cancer Center. He and his colleagues are researching new ways of making prostate cancer cells more sensitive to chemotherapy and hormonal therapy.
Clinical Associate Professor, Hematology/Oncology - School of Pharmacy
Associate Professor, Precision Medicine - Graduate School of Biomedical Sciences
The Medical College of Wisconsin
Milwaukee, WI